Back to search
Generated on www.datasnoop.be
Scheutlaan, 46-50, 1070 AnderlechtNACE 21201 — Vervaardiging van geneesmiddelen
Key FinancialsFY2024
Revenue
€15.6M
↑ 0.5%
EBITDA
€1.9M
↑ 8.4%
Margin
12.5%
Employees
91
↑ 1.4%
Leverage
1.4x
Net Debt / EBITDA
Equity Ratio
39.2%
Equity / Assets
Int. Coverage
12.6x
EBITDA / Int. Exp
DSO
176d
Days to collect
DPO
133d
Days to pay
Financial History Summary
| Year | Revenue | EBITDA | Margin | Net Profit | FTE |
|---|---|---|---|---|---|
| 2024 | €15.6M +€81K ▲ +0.5% | €1.9M +€150K ▲ +8.4% | 12.5% | €947K -€41K ▼ -4.2% | 91 +€1 ▲ +1.4% |
| 2023 | €15.5M +€3.7M ▲ +31.1% | €1.8M +€1.3M ▲ +301.0% | 11.6% | €989K +€919K ▲ +1331.1% | 90 +€9 ▲ +10.7% |
| 2022 | €11.8M | €448K | 3.8% | €69K | 81 |
Key People
No administrator data
Recent Publications
No publications yet
Key Shareholders
No shareholder data
Key Subsidiaries
No subsidiary data